S

Sublimity Therapeutics

11 employees

Sublimity Therapeutics Limited (Sigmoid Pharma Limited), a specialty pharmaceutical company focused on the treatment of ulcerative colitis.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Pharmaceutical
Wellness
Delivery
Health Care

Date founded

2000

Funding rounds raised

Total raised

$64M

from 3 investors over 3 rounds

S

Sublimity Therapeutics raised $64M on May 22, 2018

Investors: OrbiMed Advisors and Longitude Capital

S

Sublimity Therapeutics raised $6.4M on September 29, 2014

Investors: Pendopharm

FAQ